BILL announces executive leadership changes effective Q4 fiscal 2026
Get Alerts BILL Hot Sheet
Join SI Premium – FREE
BILL (NYSE: BILL) announced several executive leadership appointments and organizational changes set to take effect in the fourth quarter of fiscal 2026, according to a company press release.
Michael Cieri, currently executive vice president and general manager of software solutions, will be promoted to chief product officer. In this role, Cieri will lead a newly created product organization that combines software solutions, payments, and financial services under unified leadership.
Eric Chan, distinguished engineering fellow and founding engineer at BILL, has been appointed chief technology officer, replacing Ken Moss, who will depart the company and transition to an advisory role. Chan previously served as the company's first CTO and has been with the engineering executive team for nearly 20 years.
John Rettig, currently president and chief operating officer, will assume the newly created role of chief strategy and transformation officer. Rettig has been with BILL for more than a decade and will maintain oversight of operational execution while focusing on enterprise strategy and long-term growth initiatives.
Sarah Acton, chief customer officer, will depart BILL after almost five years on the executive leadership team. The company expects to announce a new chief revenue officer in the coming weeks. Acton will continue as CCO and then transition to an advisory role to support the incoming CRO.
Mary Kay Bowman, executive vice president and general manager of payments and financial services, will also depart the company and continue as an advisor. Bowman joined BILL in 2024 and led initiatives including Supplier Payments Plus and BILL Cash Account.
BILL provides financial operations services to nearly 500,000 businesses and processes approximately 1% of U.S. GDP annually through its platform.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Laser Photonics CEO takes leave, EVP named interim president
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
- DXL board reviews revised $0.84-per-share takeover bid from Zodiac
Create E-mail Alert Related Categories
Corporate News, Management ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share